These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2023393)

  • 1. [Control of the effectiveness of the hypolipidemic effects of miscleron and phenformin].
    Dil'man VM; Kovaleva IG
    Klin Med (Mosk); 1991 Jan; 69(1):42-4. PubMed ID: 2023393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
    Gavelli MS; Vitaliano E; Serra T; Rossi FG; Rizzuti A; Caridis R; Tozzi J
    Clin Ter; 1990 May; 133(3):145-50. PubMed ID: 2142901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 4. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Evans RJ; Howard AN; Hyams DE
    Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer].
    Vasil'eva IA; Bershteĭn LM; Ostroumova MN; Dil'man VM
    Vopr Onkol; 1980; 26(9):34-6. PubMed ID: 7423902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperlipoproteinemias (author's transl)].
    Crepaldi G; Fellin R; Briani G; Baggio G; Baiocchi MR
    G Ital Cardiol; 1974; 4(3):332-40. PubMed ID: 4367439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of parachlorophenoxyisobutyric acid (CPIB acid) and of diet on blood cholesterol and on the beta-alpha lipoprotein ratio in aged subjects].
    Bronzini A; Di Gregorio D; Scotti G
    G Gerontol; 1969 Nov; 17(11):1067-75. PubMed ID: 5397791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of Atromid-S on thrombogenic factors].
    Cotton RC
    Minerva Med; 1971 Sep; 62(72):3466-8. PubMed ID: 5097218
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a chronic therapy with the pineal hormone melatonin on cholesterol levels in idiopathic hypercholesterolemic patients.
    Pittalis S; Lissoni P; Giani L; Casati M; Kropacek N; Orfanò S; Giavolucci F; Merlini D
    Recenti Prog Med; 1997 Sep; 88(9):401-2. PubMed ID: 9323901
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercholesterolemia in ExHC rats and lipid-lowering drug: a screening method for new hypocholesterolemic agents.
    Kitazaki T; Tsuda M; Matsumura H; Ohtagaki T; Imai Y
    Artery; 1981; 9(6):414-24. PubMed ID: 6802106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenformin on induced hypercholesterolemia.
    Abraham GJ; Keny KV
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):365-9. PubMed ID: 5473796
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of phenformin hydrochloride on serum cholesterol, triglycerides and body weight of nondiabetic hypercholesterolemic subjects.
    Burstein J; Jakobson T; Lindell KA; Nikiforow RE
    Ann Med Intern Fenn; 1968; 57(1):15-21. PubMed ID: 5726760
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 14. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar; 35(891):19-22. PubMed ID: 8433674
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of ezetimibe in clinical practice.
    Jurado J; Seip R; Thompson PD
    Am J Cardiol; 2004 Mar; 93(5):641-3. PubMed ID: 14996600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects on lipid metabolism of inhibitors of cholesterol synthesis].
    Guarini G; Costa C; Trimarco C; Santese D; Vitaliano E
    Clin Ter; 1988 Apr; 125(1):41-50. PubMed ID: 2974357
    [No Abstract]   [Full Text] [Related]  

  • 19. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased superoxide anion production by platelets in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Caccese D; Pulcinelli FM; Lenti L; Magnaterra R; Martini F; Lauro R; Violi F
    Thromb Haemost; 2002 May; 87(5):796-801. PubMed ID: 12038779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.